Search clinical trials for: Telatinib
Total 189 results
-
Qilu Pharmaceutical Co., Ltd.UnknownAdvanced Breast CancerChina
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Puma Biotechnology, Inc.Completed
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Pierre Fabre MedicamentNot yet recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterNo longer available
-
Pierre Fabre Pharma GmbHiOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AGActive, not recruiting
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
Taizhou EOC Pharma Co., Ltd.Fountain Medical Development Co., Ltd.CompletedSolid Tumor, AdultChina
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
Hutchison Medipharma LimitedCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, HepatocellularChina, Taiwan, Korea, Republic of
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Withdrawn
-
Hutchison Medipharma LimitedTerminated
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedAdvanced Solid CancerChina
-
M.D. Anderson Cancer CenterWithdrawn
-
Baylor Research InstituteNot yet recruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Puma Biotechnology, Inc.Completed
-
Second Affiliated Hospital, School of Medicine,...Sun Yat-sen University; Peking University International Hospital; Zhejiang UniversityNot yet recruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
Virginia Commonwealth UniversityGlaxoSmithKline; Puma Biotechnology, Inc.RecruitingOvarian Cancer | Advanced Solid TumorUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Puma Biotechnology, Inc.Completed
-
Cascadian Therapeutics Inc.Completed
-
University Health Network, TorontoRecruitingBreast Cancer | HER2-positive Breast CancerCanada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Jules Bordet InstituteWithdrawn
-
Puma Biotechnology, Inc.CompletedHealthy SubjectsUnited States
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.CompletedHepatic InsufficiencyRussian Federation
-
Taizhou EOC Pharma Co., Ltd.Shanghai Zhongshan Hospital; Shanghai East HospitalUnknown
-
Puma Biotechnology, Inc.CompletedNeoplasms | Breast NeoplasmsUnited States, Belgium, India, China, Russian Federation, Mexico, France
-
Hallym University Medical CenterRecruitingGastric Cancer | Gastroesophageal-junction CancerKorea, Republic of
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
Andrew Hendifar, MDEOC PharmaActive, not recruitingHepatocellular Carcinoma | Gastric CancerUnited States
-
ACT Biotech, IncCompletedGastric CancerSpain, United States
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Puma Biotechnology, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, France, Hungary, Poland, Spain
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States
-
Sun Yat-sen UniversityRecruitingRecurrent Hepatocellular CarcinomaChina
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, Korea, Republic of, China, United Kingdom, Canada, France, Australia, Denmark, Switzerland, Japan, Malaysia, Italy, Singapore, Taiwan, Belgium, Croatia, Czechia, Romania, Germany, Bahamas, Brazil, Bulgaria, Colombia and more
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom